Literature DB >> 19469042

Extended donor criteria in lung transplantation.

Phil Botha1.   

Abstract

PURPOSE OF REVIEW: Despite improvements in respiratory care and lung transplant organ allocation algorithms, waiting lists continue to grow worldwide. Attempts at improving organ donation rates have generally had little impact on the increase in the number of transplants performed. Improved use of the available pool of cadaveric organ donors, therefore, represents one of few immediately available strategies to alleviate organ shortages. RECENT
FINDINGS: The once-strict lung donor selection criteria have, of necessity, been relaxed and, in many instances, this situation has been to no apparent detrimental effect on posttransplant outcome. There is, however, some evidence that extension of donor acceptability in some respects leads to poorer early outcomes, mainly by increasing the rate of early graft dysfunction. The extension of selection criteria to allow the maximum number of safe lung transplants, coupled with aggressive and appropriate donor management is, therefore, of particular current relevance to the lung transplantation community.
SUMMARY: Although the available evidence for and against the commonly used lung donor selection criteria leaves many questions unanswered, it can help decrease the large number of uncertainties that be falls the practice of lung donor selection and recipient matching.

Entities:  

Mesh:

Year:  2009        PMID: 19469042     DOI: 10.1097/mot.0b013e328326c834

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  8 in total

1.  ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine.

Authors:  Gaëtane C Michaud; Colleen L Channick; Chad R Marion; Robert M Tighe; James A Town; Andrew M Luks; Jeremy B Richards; Sucharita Kher; Prerna Mota; Gina Hong; Natalie E West; Craig Rackley; Luke Neilans; Josanna Rodriguez-Lopez; Hilary DuBrock; Cassie C Kennedy; Diana J Kelm; Carey C Thomson
Journal:  Ann Am Thorac Soc       Date:  2015-09

Review 2.  Advanced therapies for COPD-What's on the horizon? Progress in lung volume reduction and lung transplantation.

Authors:  Michael A Trotter; Peter M Hopkins
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

Review 3.  Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality.

Authors:  Geert Meyfroidt; Jan Gunst; Ignacio Martin-Loeches; Martin Smith; Chiara Robba; Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2019-02-11       Impact factor: 17.440

4.  The incidence of potential missed organ donors in intensive care units and emergency rooms: a retrospective cohort.

Authors:  Demetrios J Kutsogiannis; Sonal Asthana; Derek R Townsend; Gurmeet Singh; Constantine J Karvellas
Journal:  Intensive Care Med       Date:  2013-05-24       Impact factor: 17.440

5.  Use of lung allografts from brain-dead donors after cardiopulmonary arrest and resuscitation.

Authors:  Anthony W Castleberry; Mathias Worni; Asishana A Osho; Laurie D Snyder; Scott M Palmer; Ricardo Pietrobon; R Duane Davis; Matthew G Hartwig
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 21.405

6.  Sequence of refusals for donor quality, organ utilization, and survival after lung transplantation.

Authors:  Eshita Singh; Marc Schecter; Christopher Towe; Raheel Rizwan; Bryant Roosevelt; James Tweddell; M Monir Hossain; David Morales; Farhan Zafar
Journal:  J Heart Lung Transplant       Date:  2018-08-17       Impact factor: 10.247

7.  Ex-vivo recruitment and x-ray assessment of donor lungs in a challenging retrieval from a donor supported by lvad using the portable normothermic perfusion system: a case report.

Authors:  Marco Schiavon; Francesca Calabrese; Guido Di Gregorio; Monica Loy; Giuseppe Marulli; Alessandro Rebusso; Fiorella Calabrese; Federico Rea
Journal:  J Cardiothorac Surg       Date:  2017-05-18       Impact factor: 1.637

8.  Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation.

Authors:  Hanbo Chen; Jussi Tikkanen; R Gabriel Boldt; Alexander V Louie
Journal:  Radiat Oncol       Date:  2018-08-07       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.